Zinzino Reports Impressive Revenue Growth in August 2024
Zinzino Group has announced a remarkable revenue increase of 39% compared to the same month last year.
In August, Zinzino's sales markets generated a revenue of SEK 166.4 million, which is a 38% rise from SEK 120.6 million. Notably, Faun Pharma saw a significant boost in external sales, soaring by 58% to SEK 12.3 million, up from SEK 7.8 million last year. Overall, the Group's revenues climbed to SEK 178.7 million, marking a 39% improvement from SEK 128.4 million.
From January to August 2024, the total accumulated revenue rose by 21%, reaching SEK 1,309.4 million, compared to SEK 1,080.3 million in the previous year.
Revenue Distribution Breakdown
Here's how the revenues are distributed across different regions:
The Nordics: SEK 23.7 million (slightly up from SEK 23.6 million, 0% change) with year-to-date totals at SEK 188.6 million (down from SEK 191.6 million, -2% change).
Central Europe: SEK 45.5 million (up from SEK 33.4 million, 36% growth) with year-to-date totals of SEK 345.4 million (up from SEK 266.0 million, 30% increase).
East Europe: SEK 31.3 million (up from SEK 27.1 million, 15% increase) with year-to-date totals of SEK 251.9 million (up from SEK 249.4 million, 1% growth).
South & West Europe: SEK 33.3 million (up from SEK 19.0 million, 75% increase) with year-to-date totals reaching SEK 226.9 million (up from SEK 153.8 million, 48% increase).
The Baltics: SEK 6.7 million (up from SEK 6.6 million, 2% increase) leading to year-to-date totals of SEK 62.2 million (up from SEK 58.5 million, 6% increase).
North America: SEK 15.5 million (up from SEK 6.9 million, 125% surge) with year-to-date totals at SEK 113.6 million (up from SEK 53.3 million, 113% increase).
Asia-Pacific: SEK 9.1 million (up from SEK 3.2 million, 184% increase) with a year-to-date total of SEK 37.3 million (no change from last year).
Africa: SEK 1.3 million (up from SEK 0.8 million, 63% increase) totaling SEK 9.6 million year-to-date (up from SEK 9.0 million, 7% increase).
Key Highlights from the Sales Report
Here are the overall figures for Zinzino in August 2024:
- Total Sales: SEK 178.7 million (up from SEK 128.4 million, 39% increase).
- Accumulated Revenue: SEK 1,309.4 million (up from SEK 1,080.3 million, 21% growth).
- Faun Pharma Performance: Achieved record external sales growth, reaching SEK 12.3 million.
About Zinzino
Zinzino AB is committed to enhancing health and wellness through its range of nutritional products and innovative business strategies. Their global footprint reflects their dedication to providing tailored wellness solutions for diverse markets.
For further inquiries, please contact:
Dag Bergheim Pettersen, CEO of Zinzino, is available at +47 (0) 932 25 700. For more information about their services and products, please visit zinzino.com.
Frequently Asked Questions
What percentage did Zinzino's revenue grow in August 2024?
Zinzino's revenue grew by 39% compared to the previous year.
What was the total revenue for Zinzino in August 2024?
The total revenue for Zinzino in August 2024 was SEK 178.7 million.
How did Faun Pharma perform in August 2024?
Faun Pharma's external sales increased by 58%, reaching SEK 12.3 million.
How much did Zinzino's accumulated revenue increase from January to August 2024?
The accumulated revenue increased by 21%, totaling SEK 1,309.4 million.
What regions contributed to Zinzino's sales growth?
Zinzino experienced robust sales growth across various regions, including the Nordics, Central Europe, and North America.
